Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Aaron Noles

Neurology Fort Walton Beach, FL Medical Doctor

NPI 1982066346 CMS profile 10187482

1106 Hospital Rd, Fort Walton Beach, FL 32547

Open in the dashboard

General payments

$1,579

85 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Aaron Noles of Fort Walton Beach, FL is reported in the CMS Open Payments database as having received $1,579 across 85 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 51st percentile of Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $372 16
2023 General $48 3
2022 General $926 53
2021 General $233 13

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Aaron Noles
  • Neurology median
  • Middle half of Neurology
  • National median

In program year 2025, general payments to Aaron Noles were reported at $372. Among 11,022 Neurology profiles paid that year, the median was $457 and the middle half received between $118 and $2,344.

Show as a table
Year Aaron Noles Neurology median Middle half National median
2019 $0 $474 $118–$2,177 $163
2020 $0 $367 $82–$2,309 $114
2021 $233 $438 $104–$2,547 $132
2022 $926 $442 $103–$2,388 $149
2023 $48 $464 $119–$2,312 $160
2024 $0 $468 $119–$2,323 $164
2025 $372 $457 $118–$2,344 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $395 28 payments
  2. GRT US Holding, Inc. $139 2 payments
  3. Novartis Pharmaceuticals Corporation $116 6 payments
  4. Amgen Inc. $86 5 payments
  5. Lundbeck LLC $81 4 payments
  6. Lilly USA, LLC $65 4 payments
  7. Biohaven Pharmaceutical Holding Company Ltd. $61 4 payments
  8. Genzyme Corporation $59 3 payments
  9. Allergan Inc. $58 3 payments
  10. Pfizer Inc. $53 2 payments
  11. Other $465 24 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $1,572 84 payments
  2. Education $7 1 payment
Products named General payments · program years 2021–2025
  1. QULIPTA $220 13 payments
  2. BOTOX Botox Therapeutic $208 9 payments
  3. Qutenza $139 2 payments
  4. KESIMPTA $89 5 payments
  5. MAYZENT $89 5 payments
  6. AIMOVIG $86 5 payments
  7. BOTOX Hyperhydrosis $72 3 payments
  8. NURTEC ODT Primary Care $61 4 payments
  9. AUBAGIO $59 3 payments
  10. NURTEC ODT Pain $53 2 payments
  11. Other $730 46 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 10 billing codes

Paid by Medicare

$63,884

Medicare's payments for the services billed

Medicare patients

419

Average age 77

Services billed

712

224 women, 195 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 53%
Chronic kidney disease 50%
Ischemic heart disease 46%
Diabetes 44%
Depression 41%
COPD 38%
Heart failure 37%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

85 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record